NEWS
World Sleep Day – let’s talk about Narcolepsy
Why is it important to talk today? It has a profound impact on the lives of sufferers but is also very difficult to diagnose. For example, according to global statistics, about 500-600 people are suffering from Narcolepsy in Lithuania, but only 30 are currently...
Good news from Norameda on the International Rare Disease Day
Until 2024, the Norameda Special Care Medicine Department has been actively working with two main rare diseases: Alpha-mannosidosis and Hereditary Leber optic Neuropathy. This year, Norameda introduced a new option in treating Fabry disease and is entering a new field...
Amendment to the Polish Reimbursement Act – key changes
At the end of 2023, an Amendment to the Reimbursement Act came into force in Poland. We present the main changes with the comment from the CEO of Norameda of the Polish Branch, Arvydas Norvaišas. "Poland's pharmaceutical community has met these amendments with a...
A professional from Ukraine steps in as Norameda’s Alliance Manager
With twenty years of experience in the pharmaceutical field most of his career at Pfizer, Ivan Chervotkin joined the Norameda team as Alliance Manager for Baltic states in spring 2023. "The company is one I have long admired for its business-oriented approach and...